Search Within

Shanu Modi

  1. "2012"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Breast Medicine Service (13)
  2. Department of Medicine (13)
  3. Solid Tumor Oncology Division (13)
  4. Survivorship Research (7)
  5. Epidemiology and Biostatistics (6)
  6. GSK Faculty (6)

More Groups

People
  1. Clifford Hudis (7)
  2. Sarat Chandarlapaty (5)
  3. Sujata Patil (5)
  4. Komal Jhaveri (4)
  5. Angemael Syldor (3)
  6. Chau Dang (3)

More People

Years
  1. 2012 (13)
Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (2)
  3. Clinical Cancer Research (2)
  4. Advances in Pharmacology (1)
  5. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (4)
  3. Elsevier B.V. (1)
  4. Elsevier Inc. (1)
  5. Sage Publications (1)
  6. Wiley Blackwell (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Results from a phase Ib study of trastuzumab emtansine (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab
    Meeting Abstract

    Modi, S.; Elias, A. D.; LoRusso, P.; Samant, M.; Guardino, E.; Althaus, B.; Krop, I. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors (HSP90i)
    Meeting Abstract

    Jhaveri, K. L.; Iyengar, N. M.; Corben, A.; Patil, S.; Akram, M.; Towers, R.; Sakr, R.; Hudis, C.; King, T. A.; Rosen, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine
    Journal Article

    Krop, I. E.; LoRusso, P.; Miller, K. D.; Modi, S.; Yardley, D.; Rodriguez, G.; Guardino, E.; Lu, M.; Zheng, M.; Girish, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer
    Journal Article

    Beeram, M.; Krop, I. E.; Burris, H. A.; Girish, S. R.; Yu, W.; Lu, M. W.; Holden, S. N.; Modi, S.
    Cancer (2012)

    Fulltext@MSK | Save
  • HSP90 inhibitors for cancer therapy and overcoming drug resistance
    Journal Article

    Jhaveri, K.; Modi, S.
    Advances in Pharmacology (2012)

    Fulltext@MSK | Save